Последние добавленные видео:
Speaker:-Dirk-Schadendorf
-
6 лет назад
537 6 лет назад 5:17Dirk Schadendorf, ESMO 2018 – Encorafenib plus binimetinib for BRAF-mutant metastatic melanoma
-
7 лет назад
140 7 лет назад 2:45Developing alternative treatment options for advanced melanoma
-
7 лет назад
77 7 лет назад 3:10Targeted therapy or checkpoint inhibitors in melanoma: which is better?
-
11 лет назад
163 11 лет назад 19:19Rationally Designed Targeted Therapies: BRAF Inhibitors for Personalized Cancer Treatment
-
2 года назад
194 2 года назад 3:21Unmet needs in nonmelanoma skin cancer
-
2 года назад
682 2 года назад 2:54Combining nivolumab and ipilimumab in patients with resected stage IV melanoma
-
8 лет назад
139 8 лет назад 5:34Developments in melanoma – new treatment options
-
8 лет назад
327 8 лет назад 5:29Benefits and risks of treatment with ipilimumab after complete resection of Stage III melanoma
-
7 лет назад
990 7 лет назад 3:05Dabrafenib and trametinib: a promising combination for the treatment of melanoma
-
7 лет назад
48 7 лет назад 4:18Development of novel treatments in melanoma patients with BRAF mutations
-
9 лет назад
737 9 лет назад 2:58Role of BRAF mutation in the treatment for melanoma
-
8 лет назад
1017 8 лет назад 3:16Melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better PFS
-
8 лет назад
239 8 лет назад 2:33Rare mutation subgroups in melanoma and how to treat them
-
2 года назад
728 2 года назад 2:14IMMUNED: adjuvant nivolumab and ipilimumab increases OS in stage IV melanoma
-
3 недели назад
1839 3 недели назад 5:23DECWARE's Steve Deckert talks about Top 10 Weakest Links
-
329 11:48
microphonics IV
